-
The African Medical Centre of Excellence (AMCE) achieves two landmark successes as it completes its first Open-Heart Surgery and delivers West Africa’s first Stereotactic Body Radiation Therapy (SBRT) for lung Cancer
17 Dec 2025 17:22 GMT
… Body Radiation Therapy (SBRT) for lung cancer. These achievements underscore AMCE’s … , haematology, comprehensive oncology, and general medical services. The facility has … , haematology, cardiovascular care, and general medicine. The hospital has already …
-
Emergency vs Referral Routes in Lung Cancer Care
17 Dec 2025 12:37 GMT
… between emergency-diagnosed and referred lung cancer patients revealed no clear aetiological … , in the British Journal of General Practice.
LIMITATIONS:
The reliance on … focused solely on patients with lung cancer, without examining healthcare use patterns …
-
Research matters: How folate deficiency may alter genes to promote cancer
17 Dec 2025 18:59 GMT
… including lung tumors.
“Researchers have known about these genetic changes … contributor to lung cancer development and progression.”
Lung cancer is the … aggressive, faster-spreading lung tumors and had lower … due to diet, genetics, medication or local …
-
Multi-Omics Identifies CYP2B6 as Key in Lung Cancer
17 Dec 2025 10:02 GMT
… -small cell lung cancer (NSCLC), placing the gene CYP2B6 at … for the majority of lung cancer cases worldwide, remains … of non-small cell lung cancer.
Article References:
Tripathi, … lung cancernon-small cell lung cancer researchtherapeutic implications of …
-
Will Australia’s Lung Cancer Screening Help the Indigenous?
17 Dec 2025 09:38 GMT
… praised the opportunity to detect lung cancers that otherwise might have been … for Indigenous Australians to access lung cancer screening for numerous reasons, said … see a general practitioner,” he said.
“But the National Lung Cancer Screening Program …
-
Glenmark secures multi-regional rights for Hansoh’s lung cancer drug Aumolertinib
17 Dec 2025 02:22 GMT
… Ltd for Aumolertinib, a third-generation EGFR tyrosine kinase inhibitor for … treatment of non-small cell lung cancer (NSCLC).
Under the agreement, Glenmark … serve patients with EGFR-mutated lung cancer,” he said.
Aumolertinib, marketed as …
-
Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib
16 Dec 2025 16:45 GMT
… ., Ltd. for Aumolertinib, a third-generation EGFR tyrosine kinase inhibitor (EGFR … tiered royalties on net sales generated in Glenmark’s licensed territories … utility across different stages of lung cancer.
Notably, Aumolertinib marked a significant …
-
Trethera Receives $2.7 Million NIH Grant, Validating the Potential of First-in-Class TRE-515 to Overcome KRAS Inhibitor Resistance in Lung Cancer
16 Dec 2025 16:09 GMT
… treat non-small cell lung cancer (NSCLC). Lung cancer is responsible for … . “Securing this NIH lung cancer grant continues our multiple … escape route used by lung cancer cells.” Dr. Steve Dubinett … two biosynthetic pathways that generate DNA precursors. It is …
-
‘UK at the Half’: Markey offers same-day lung cancer diagnosis and treatment
16 Dec 2025 12:34 GMT
… Cancer Center is transforming lung cancer care with advanced robotic … removal of early-stage lung cancers in a single day. … emphasizes the importance of lung cancer screening for adults aged … professions colleges teach the next generation of doctors, nurses, …
-
IBI318 Plus Lenvatinib Tackles Resistant Lung Cancer
16 Dec 2025 06:48 GMT
… non-small cell lung cancer (NSCLC) who … immune markers and gene expression profiles suggested … non-small cell lung cancer treatment resistant to … resistanceinnovative cancer therapeuticslenvatinib lung cancer treatmentovercoming immune resistancePhase …